Categories: HealthcareNews

RSM Deploys AI-Powered Health Reporting Solution Using Microsoft Technologies to Support Hawai’i State Department of Health Program

CHICAGO, Jan. 6, 2026 /PRNewswire/ — RSM US LLP (“RSM”) the leading provider of assurance, tax and consulting services for the middle market – has implemented an AI-powered platform built on Microsoft technologies to enhance adverse event reporting within the program administered in Hawai’i. The solution, developed with analytics contributions from the University of Hawai’i at Mānoa, applies AI to improve detection of risks and unreported incidents, enabling faster intervention and better participant outcomes. 

The platform analyzes healthcare data to identify patterns, flag potential unreported incidents and identify individuals at heightened risk of adverse events—ultimately supporting improving health outcomes and earlier interventions. The first phase was deployed within the Hawai’i Developmental Disabilities Division, which serves approximately 3,600 active participants.

“The Hawai’i Department of Health is setting a powerful example of how public agencies can embrace AI to drive meaningful change,” said Robbie Beyer, Director of Data & AI, RSM US LLP. “Aligned with RSM’s digital first strategy, this platform enables real-time risk detection and early intervention—demonstrating the transformative role AI can play in public health.”

Early results indicate a 98.9% accuracy in detecting risk patterns, highlighting the system’s potential  to transform how healthcare risks are identified and addressed using AI.

Key benefits and impact:

  • Early detection of high-risk and unreported adverse events
  • Improved case management and care coordination
  • Enhanced service quality and participant outcomes
  • Cost savings through proactive intervention
  • Scalable framework for statewide and national replication

Built on Microsoft Azure, the system integrates Azure SQL, Azure AI Foundry, Power BI and other Microsoft Data & AI tools to analyze claims and case management data in near real-time. This enables health professionals to act faster, prevent harm and improve care delivery. RSM led the design and implementation of the platform’s secure, scalable data architecture, equipping case managers with interactive dashboards that visualize participating risk levels, track overdue reviews and flag concerns —supporting smarter, proactive decision-making.

Research faculty from the University of Hawai’i at Mānoa contributed model development and exploratory analytics. This cross-sector collaboration exemplifies how government, academia and industry can come together to address complex healthcare challenges.

The deployment aligns with broader modernization initiatives, leveraging Microsoft Azure’s HIPAA-compliant infrastructure, disaster recovery planning and statewide AI readiness assessments.

About RSM US LLP

RSM empowers middle market companies worldwide to take charge of change. The clients we serve are the engine of global commerce and economic growth. Our unique middle market perspective makes RSM the natural choice for growth-oriented, internationally active organizations seeking relevant insights and tailored, innovative solutions for a complex and changing world. With a global reach spanning more than 120 countries, we instill confidence in a world of change by bringing the full power of RSM to make a lasting impact on our clients, colleagues and communities. For more information, visit rsmus.com, like us on Facebook and/or connect with us on LinkedIn.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/rsm-deploys-ai-powered-health-reporting-solution-using-microsoft-technologies-to-support-hawaii-state-department-of-health-program-302653435.html

SOURCE RSM US LLP

Staff

Recent Posts

UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026

CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…

4 hours ago

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

7 hours ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

7 hours ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

7 hours ago

Best Peptides for Anti-Aging: NAD+ Delivery Methods Compared as Telehealth Platforms Expand Access (2026 Analysis)

Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…

7 hours ago

Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a…

7 hours ago